| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 369 | 412 |
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 369 | 412 |
-
| | | Operating Expenses | | Research Development | 19,507 | 19,364 | 15,236 | | Selling General and Administrative | 4,307 | 4,681 | 3,628 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (23,445) | (23,633) | (18,864) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 520 | 3,833 | 24,381 | | Earnings Before Interest And Taxes | (22,925) | (20,122) | 5,385 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (22,925) | (20,122) | 5,385 | | Income Tax Expense |
-
| 41 | 119 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (22,925) | (19,841) | 5,398 | | | Non-recurring Events | | Discontinued Operations | (200) | (322) | (132) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (23,125) | (20,163) | 5,266 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($23,125) | ($20,163) | $5,266 |
|
1.48% Nasdaq 
0.01 (1.08%) 
Income Statement
